Call us 24/7

GI Cancer Center, Chicago

Your treatment options

Breast Cancer Center

The clinicians with the Gastrointestinal (GI) Cancer Center at Cancer Treatment Centers of America® (CTCA), Chicago, are committed to offering state-of-the-art treatments for patients with gastrointestinal cancer.

Our multidisciplinary team of board-certified medical oncologists, surgical oncologists, radiation oncologists and gastroenterologists work together with our integrative care providers and each patient to deliver quality clinical care with a patient-centered approach.

Our GI Cancer Center treats all gastrointestinal-related cancers, including anal, colon, esophageal, liver, pancreatic and stomach cancers, as well as neuroendocrine tumors.

We also diagnose, stage and treat precancerous conditions such as Barrett’s esophagus, a risk factor for esophageal cancer, as well as lung or breast cancers that have metastasized (or spread) to the gastrointestinal system.

After your diagnosis is confirmed, our GI Cancer Center care team will discuss your options with you and help you develop a personalized care plan tailored to your individual needs.

Our doctors are trained and experienced in treating the wide range of gastrointestinal diseases. Treatments for most gastrointestinal diseases include the following, either alone or in combination:

For patients with advanced colorectal, appendix or stomach cancer, surgery to reduce the size of a tumor may be recommended in combination with hyperthermic intraperitoneal chemotherapy (HIPEC), a highly concentrated, heated chemotherapy treatment delivered directly to the abdominal cavity during surgery.

Within the GI Cancer Center, the gastroenterology team offers patients a number of minimally invasive techniques to diagnose and treat tumors and help reduce cancer-related symptoms. The team combines diagnostic test and state-of-the-art technologies with non-surgical techniques, such as colonoscopy to examine the inner lining of the colon and rectum, and endoscopic mucosal resection to remove abnormal tissue. The team also uses endoscopic ultrasound with fine-needle biopsy and radiofrequency ablation and other tools to treat esophageal, pancreatic, bile duct and colorectal cancers.

For patients with early-stage esophageal cancer or non-cancerous polyps in the intestines, our gastroenterologists may combine state-of-the-art technologies with non-surgical techniques, such as endoscopic mucosal resection, to remove abnormal tissue. They also use a wide range of tools, such as endoscopic ultrasound with fine-needle biopsy and radiofrequency ablation, to treat esophageal, pancreatic, bile duct and colorectal cancers.

Meet our GI Cancer Center team

Pankaj Vashi - Chair, CTCA Department of Medicine

Pankaj Vashi

Vice Chief of Staff, CTCA Chicago

Bruce Gershenhorn - Medical Oncologist

Bruce Gershenhorn

Medical Director, Lung Cancer Center, CTCA Chicago

Evan Pisick - Medical Oncologist

Evan Pisick

Medical Oncologist, CTCA Chicago

Revathi Suppiah - Medical Oncologist

Revathi Suppiah

Medical Oncologist, CTCA Chicago

Hatem Halabi - Assistant Director of the GI Cancer Institute

Hatem Halabi

Vice Chair, CTCA Department of Surgery

Kamal Patel - Medical Director, Radiation Oncology

Kamal Patel

Medical Director, Radiation Oncology, CTCA Chicago

Karen Smorowski - Radiation Oncologist

Karen Smorowski

Radiation Oncologist, CTCA Chicago

Kenny S. Yoo - Interventional Radiologist

Kenny S. Yoo

Director, Interventional Radiology, CTCA Chicago

Bradford Tan - Chair Department of Pathology and Laboratory Medicine

Bradford Tan

Chair, CTCA Department of Pathology and Laboratory Medicine

Elham Abboud - Assistant Medical Director of Pathology and Laboratory Medicine

Elham Abboud

Assistant Medical Director of Pathology and Laboratory Medicine, CTCA Chicago

See all CTCA physicians

A comprehensive team approach

The GI Cancer Center team at CTCA® Chicago is committed to a multidisciplinary approach to care. After diagnosis, each patient is evaluated by a medical oncologist, who then builds the appropriate team based on the patient’s needs. Then the entire team, along with the patient, works together to develop a treatment plan designed to specifically for the patient. Throughout treatment and follow up, the team meets regularly to ensure that everyone is in alignment with the needs of the patient.

This collaborative, personalized approach allows us flexibility along the treatment journey, while also fostering an environment where experts in a variety of disciplines work together, all under one roof. New options may arise or different goals may be proposed during the course of treatment. We monitor the patient throughout treatment and adjust the care plan as needed.

Integrative cancer care

As a patient at the GI Cancer Center, your team also works closely with other supportive care providers to help manage additional disease- and treatment-related side effects, such as nausea and vomiting. These supportive services may include a pain management physician, as well as naturopathic, mind-body and spiritual support providers.

Because of the digestive tract’s role in processing food and waste, many patients with gastrointestinal disease have difficulty with digestive function. That’s why nutritional support is a key component of the GI Cancer Center’s approach. The center has a dedicated clinical dietitian on staff to work with patients in developing a healthy, balanced and appetizing nutrition plan. If patients become malnourished, our dietitian is also available to help them establish healthy lifestyle and eating habits to help improve their condition.

Learn more about the value of integrated cancer care

" My wife and family supported me through this hard time, and with their care along with the care provided by CTCA, I can now be here for them. I am so thankful God led us to CTCA!"

Mike Fincham

Mike F.

Colorectal Cancer

MORE ABOUT MIKE

More About MIKE

GI cancer clinical trials

 

Our oncologists are committed to improving treatment options for gastrointestinal cancer patients. As part of that commitment, the GI Cancer Center offers qualified patients carefully selected clinical trials in studying new treatment approaches like immunotherapy for pancreatic cancer and other innovative research.

Although clinical trials are not available to all patients, they may offer some patients options that would otherwise be unavailable to them. Your care team will discuss whether you qualify for any of our ongoing clinical trials, and if so, help you enroll.

Learn more about the CTCA clinical trials program and which trials are available

For general questions, contact an Oncology Information Specialist at 888-841-9129.

Where we are located

CTCA Chicago

Breast Cancer Center
2520 Elisha Ave.
Zion, IL 60099
New Patients: 888-552-6760
Existing Patients: 847-510-CTCA

Get directions

Outpatient Care Center, Downtown Chicago

160 E. Illinois St.
Chicago, IL 60611
New Patients: 888-552-6760
Existing Patients: 312-667-CTCA

Get directions

Outpatient Care Center, Gurnee

202 S. Greenleaf St., Suite E
Gurnee, IL 60031
New Patients :888-552-6760
Existing Patients: 847-857-CTCA

Get directions

Expert care

A team of experts centered on your treatment, caring for the whole person.

Our experts

New research

Offering clinical trials on new and emerging cancer treatment options.

View our clinical trials
notes

Insurance plans

We accept a wide range of insurance plans.

Verify your insurance